WHO identifies counterfeit versions of Covishield in India
Darpan News Desk IANS, 18 Aug, 2021 08:25 PM
The World Health Organisation (WHO) said it has identified counterfeit versions of India's primary Covid vaccine, Covishield, BBC reported.
The doses were seized by authorities in India and Africa between July and August, a WHO statement said.
It also said the vaccine's maker, the Serum Institute of India, confirmed that the doses were fake.
The WHO warned that fake vaccines "pose a serious risk to global public health".
It called for their removal from circulation.
Covishield is the Indian-made version of AstraZeneca's jab and is the most widely used vaccine in India with more than 486 million doses administered so far.
Serum had supplied millions of Covishield vaccines to countries in Asia, Africa and South America - as part of deals that were inked with various governments and the global Covax scheme for poorer countries.
India, which is the second worst-affected country in the world, aims to vaccinate all its people by the end of this year.
About 13 per cent of the population has been fully vaccinated since the beginning of the drive in January.
Tension prevailed in a Punjab village on Sunday after a horrific incident in which a Dalit labourer was allegedly beaten up and forced to drink urine by upper-caste men and later succumbed to his injuries at the Post Graduate Institute of Medical Education and Research
The Supreme Court on Friday held former Ranbaxy promoters Malvinder Singh and Shivinder Singh guilty of contempt for violating its order that had asked them not to divest their shares in Fortis Healthcare Limited.
A six-year-old boy died after falling into a vessel with steaming sambar in a private school in Kurnool district of Andhra Pradesh with education and police authorities finding alleged negligence on the part of the management for the horrific death.
A part of the rights issue was funded by RHC and the Singh brothers, who Radha Soami sect head admits to financial deals with Ranbaxy brothers spent a total of Rs 440 crore on the transaction.
